Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease
about
Structural basis for recognition of the translocated intimin receptor (Tir) by intimin from enteropathogenic Escherichia coliThe role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunitiesEnteric infection with Citrobacter rodentium induces coagulative liver necrosis and hepatic inflammation prior to peak infection and colonic diseaseCXCL9 contributes to antimicrobial protection of the gut during citrobacter rodentium infection independent of chemokine-receptor signalingRole of class 1 serine protease autotransporter in the pathogenesis of Citrobacter rodentium colitis.Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis.Epithelial p38alpha controls immune cell recruitment in the colonic mucosa.Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections.Citrobacter rodentium lifA/efa1 is essential for colonic colonization and crypt cell hyperplasia in vivo.Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentiumMouse model of enteropathogenic Escherichia coli infection.Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infectionCitrobacter rodentium, the causative agent of transmissible murine colonic hyperplasia, exhibits clonality: synonymy of C. rodentium and mouse-pathogenic Escherichia coli.Exploitation of host cells by enteropathogenic Escherichia coli.Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentiumLocus of enterocyte effacement from Citrobacter rodentium: sequence analysis and evidence for horizontal transfer among attaching and effacing pathogens.Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice.Helminth-primed dendritic cells alter the host response to enteric bacterial infectionLsaA, an antigen involved in cell attachment and invasion, is expressed by Lawsonia intracellularis during infection in vitro and in vivo.Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies.An N-ethyl-N-nitrosourea (ENU)-induced dominant negative mutation in the JAK3 kinase protects against cerebral malariaModulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen citrobacter rodentium in infected miceThe role of Galectin-1 and Galectin-3 in the mucosal immune response to Citrobacter rodentium infection.Novel changes in NF-{kappa}B activity during progression and regression phases of hyperplasia: role of MEK, ERK, and p38.CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium.Microbial dysbiosis in pediatric patients with Crohn's disease.Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice.Promising immunomodulatory effects of selected strains of dairy propionibacteria as evidenced in vitro and in vivoThe apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis.Strain-dependent cellular immune responses in cattle following Escherichia coli O157:H7 colonizationThe type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.The pathogenicity of an enteric Citrobacter rodentium Infection is enhanced by deficiencies in the antioxidants selenium and vitamin E.Binding of intimin from enteropathogenic Escherichia coli to lymphocytes and its functional consequencesHost susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentiumSelective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen.Citrobacter rodentium-induced NF-kappaB activation in hyperproliferating colonic epithelia: role of p65 (Ser536) phosphorylationNon-therapeutic administration of a model antimicrobial growth promoter modulates intestinal immune responsesModulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null miceEffect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells.Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis
P2860
Q24685613-1127748C-6802-4B05-9F8D-8506200BA100Q26827989-9D266376-9B2A-48EC-968E-BD6442CF41C5Q27307208-CD7AD6D0-6769-4A02-B5BF-7C8C41F1178DQ27321362-A2AC4081-0C37-48D0-9CD9-E43004E32454Q30409278-CE323C9D-4496-4458-B13A-2963D732DECBQ33552079-9BACEAE7-5132-49D1-8B65-45EC3B9C7643Q33598575-2A503F55-A2A3-4F41-83B3-304901F37538Q33675794-619A009C-5B6E-49C0-BF9F-8515609AE886Q33716089-3FA0465B-1542-46F1-92F9-C7BD4E995552Q33769220-A9F19148-6830-4537-BA90-DEEED95B712DQ33792879-DE93AE38-5FEF-44AD-AC6D-C7838CED3AC3Q33877159-832974AC-E380-4E3D-87F1-E23C1DF8B689Q33970489-1CFCB7E5-C27D-4972-B080-058DD0C2198DQ33988491-0AE47EAE-E825-4312-8894-4AF5C5F21AA0Q34008961-9F25B8E9-D3D5-44BE-B6CB-D683DFE24110Q34009383-BC780467-A50F-45A6-9184-7B5A8F0B28AEQ34034131-CB04CB59-EE85-4A2F-9979-C1BE6E7FC145Q34088032-BBE6D803-4D20-4F91-8764-3EC46B4F46E6Q34123936-D577DF7F-E044-4ADD-A7E2-7989A12618B2Q34144392-FC14AE5D-2829-4975-9F95-8776849F8541Q34170436-05FDAC9C-AC7D-4C60-B93A-19A22D9FF826Q34184792-259B2CFE-BD50-4321-95A3-67852E8B3240Q34226867-BE71C50A-E512-4F88-A21C-879454DE28E7Q34236615-738500C4-6333-4A01-8753-EEA122DDBEDEQ34300967-DC2B6BD0-C446-4FC3-8FF3-E8A4E14C5ADFQ34353528-5E432D03-EBB9-4663-92DD-1AC17E6BB9A6Q34405854-EC9EDC9B-B0A8-4F5D-A356-F50A5DFBDA25Q34432118-559CD4BB-178A-4D11-A931-2578E18EF7BAQ34537041-3D1A0B87-DE6B-4134-AD51-5BFED3ACFDEBQ34595847-0DC6BBB1-C088-4B0D-8F75-CE5EA25D68EAQ34596147-446AC5CB-0B8A-4E29-98A5-44A59A43A93AQ34740127-CDE0C200-DC63-4F67-BA84-F7A9DCA6E932Q34933090-6D1DB173-B516-4AE2-B422-27C9CC9E131CQ35011197-FF0EB0EF-C67D-47C3-8E89-3F8C8836C19CQ35072031-E976EF02-1648-42D8-A427-8ECFB1DF6232Q35100914-44BAD2CC-1C9F-419D-8C4E-316D9E417674Q35365098-0DEB11CA-6A4C-4732-9CD9-8EEE1AEFB27BQ35454343-CA86706D-7D44-416D-942F-307A3820894AQ35508789-F0FD9650-5040-454A-88C4-DB8063E13D68Q35527184-E7B8A67D-1A16-41A0-9E4C-6FF2395C83AA
P2860
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Citrobacter rodentium infectio ...... ine inflammatory bowel disease
@ast
Citrobacter rodentium infectio ...... ine inflammatory bowel disease
@en
Citrobacter rodentium infectio ...... ine inflammatory bowel disease
@nl
type
label
Citrobacter rodentium infectio ...... ine inflammatory bowel disease
@ast
Citrobacter rodentium infectio ...... ine inflammatory bowel disease
@en
Citrobacter rodentium infectio ...... ine inflammatory bowel disease
@nl
prefLabel
Citrobacter rodentium infectio ...... ine inflammatory bowel disease
@ast
Citrobacter rodentium infectio ...... ine inflammatory bowel disease
@en
Citrobacter rodentium infectio ...... ine inflammatory bowel disease
@nl
P2093
P2860
P1476
Citrobacter rodentium infectio ...... ine inflammatory bowel disease
@en
P2093
P2860
P304
P407
P577
1999-06-01T00:00:00Z